相关实验视频
Updated: Jul 27, 2026

07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
34.6K
乳腺癌冷化在多学科环境中:为患者和医生提供实用指南
Dennis Holmes1, Geeta Iyengar2
1Adventist Health Glendale, 1505 Wilson Terrace, Suite 370, Glendale, CA 91206, USA.
Life (Basel, Switzerland)
|August 26, 2023
概括
乳腺癌冷化提供了一种对早期疾病的最小侵入性选择. 该审查为其护理标准建立了一个多学科的框架,解决了针对综合患者管理的国家指导方针的缺乏问题.
科学领域:
- 在瘤学瘤学.
- 最少侵入性的手术
背景情况:
- 乳腺癌冷消化是乳腺癌早期瘤切除术的最小侵入性替代方案.
- 目前的管理缺乏标准化的多学科方法和国家指导方针.
研究的目的:
- 建立一个多学科的框架,为乳腺癌冷治疗的护理标准.
- 为全面的患者管理提供基于证据的讨论.
主要方法:
- 文献综述. 这是一个文献综述.
- 基于证据的讨论. 基于证据的讨论.
- 框架开发. 框架开发.
主要成果:
- 一个建议的多学科框架,用于乳腺癌的冷移除管理.
- 确定关键领域的标准的护理整合.
结论:
- 一种标准化,多学科的方法对于乳腺癌冷化治疗的最佳患者结果至关重要.
- 该框架支持在没有国家指导方针的情况下整合最佳实践.
更多相关视频
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

